Omnimmune Holdings (Omnimmune Holdings) EV-to-EBITDA : -0.00 (As of May. 20, 2024)

Omnimmune Holdings EV-to-EBITDA Chart

Omnimmune Holdings Quarterly Data
	May07	Aug07	Nov07	Feb08	May08	Aug08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10
EV-to-EBITDA	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of Omnimmune Holdings's EV-to-EBITDA

For the Biotechnology subindustry, Omnimmune Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Omnimmune Holdings's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Omnimmune Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Omnimmune Holdings's EV-to-EBITDA falls into.

Omnimmune Holdings EV-to-EBITDA Calculation

Omnimmune Holdings's EV-to-EBITDA for today is calculated as:

Omnimmune Holdings's current Enterprise Value is $0.00 Mil.
Omnimmune Holdings's EBITDA for the trailing twelve months (TTM) ended in Sep. 2010 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omnimmune Holdings  (GREY:OMMH) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Omnimmune Holdings's PE Ratio for today is calculated as:

Omnimmune Holdings's share price for today is $0.0001.
Omnimmune Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2010 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.190.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Omnimmune Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Omnimmune Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Omnimmune Holdings (Omnimmune Holdings) Business Description